Goldenwell Biotech, Inc.
GWLL
Revenue
139.00
▼-19.00▼-12.03%
3 Months ChangeAssets
200.40k
▲1.43k▲0.7187%
3 Months ChangeLiabilities
196.57k
▲51.35k▲35.36%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-08-22
Form 10-Q
ID: 0001477932-24-005196
2024-05-20
Form 10-Q
ID: 0001477932-24-003169
2024-05-20
Form 8-K
ID: 0001477932-24-003149
2023-11-13
Form 10-Q
ID: 0001477932-23-008297
2023-08-17
Form 10-Q
ID: 0001477932-23-006241
2023-05-19
Form 10-Q
ID: 0001477932-23-003745
2022-11-14
Form 10-Q
ID: 0001477932-22-008556
2022-08-15
Form 10-Q
ID: 0001477932-22-006072
2022-05-18
Form 10-Q
ID: 0001477932-22-003635
2022-01-03
Form 10-Q
ID: 0001477932-22-000010